Decision Aid for Psoriatic Arthritis and Psoriasis
(DA Trial)

Recruiting in Palo Alto (17 mi)

Overseen byAlexis Ogdie-Beatty, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of Pennsylvania

No Placebo Group

Approved in 1 Jurisdiction

Trial Summary

What is the purpose of this trial?The purpose of this study is to create and test a patient decision aid that facilitates the shared decision-making process when patients with psoriasis and/or psoriatic arthritis are starting or switching to a new therapy.

Eligibility Criteria

This trial is for adults over 18 with psoriasis or psoriatic arthritis confirmed by a specialist, starting or switching to new FDA-approved treatments. It's only for patients treated at Penn clinics who can consent to participate.

Inclusion Criteria

Treated at Penn

You do not need to stop taking any medication before participating in the study.

I am starting a new treatment for psoriasis or psoriatic arthritis.

+4 more

Exclusion Criteria

I am not starting or changing any medications.

I am younger than 18 years old.

I do not have psoriasis or psoriatic arthritis.

+2 more

Participant Groups

The study aims to develop and evaluate a decision aid tool designed to help patients with psoriasis or psoriatic arthritis make informed choices about their treatment options in collaboration with their healthcare providers.

1Treatment groups

Experimental Treatment

Group I: Decision Aid TestingExperimental Treatment1 Intervention

Participants will have the opportunity to test the different decision aid prototypes while selecting new treatment/therapy.